Texas A
TrialSite News,
Roche acquired a U.S. biotech that moves to the last clinical trial stages with a drug addressing idiopathic pulmonary fibrosis.
Roche acquired a U.S. biotech that moves to the last clinical trial stages with a drug addressing idiopathic pulmonary fibrosis.
In the aftermath of a horrible tragedy, a victim's loved one is getting an outpouring of support.